For how we live.
The FDA logged the recall of the RED 62 reperfusion catheter, part of the Penumbra System used to pull clots from the brain, on 7 October. Manufacturing problems mean the device may fracture; 43 units are affected.
A draft NIH policy out for comment would require researchers to share plain-language summary results with clinical research participants for all NIH-supported studies, unless justifiably not appropriate.
The FDA logged the recall of 8,939 StatStrip Glucose and B-Ketone meters on 23 September, after a software flaw let a scanned barcode linger and file a reading to the wrong patient. It is the agency's most serious tier.
The FDA logged the recall of 2,718 Medline convenience kits on 23 September: sterile applicators in some lots could grow the mould Aspergillus penicillioides, and contaminated skin-prep risks infection or sepsis.
The FDA logged the recall of 1,640 AVID single-shot epidural trays on 23 September, because they hold sodium-chloride ampules caught in a separate Class I sterility recall that warns of possible infection.
The FDA logged the recall of 5,232 Automated Impella Controllers on 23 September, citing a possible purge-pressure sensor failure that can leave the console unable to recognise the pump's purge cassette.
One lot of Vitruvias's 1/2-grain Thyroid Tablets — 1,955 bottles sold nationwide — was pulled after testing showed the tablets carry more hormone than the label states. The FDA calls it its most serious recall class.
Two 2026 Class I recalls cover Omnipod 5 insulin pods whose soft cannula can be damaged in manufacturing, letting insulin leak instead of reaching the user. The FDA ties under-delivery to a risk of DKA.
The FDA logged a Class I recall of 35,883 boxes of the simethicone antigas product on 17 June, after softgels were contaminated with a propylene glycol-based coolant that leaked from packaging machinery.
The FDA logged the recall of 145,464 bags of 0.9% sodium chloride in 500 mL Viaflex containers on 9 September, after fiberglass particulate matter was found. It is the agency's most serious recall tier.
The Class I recall covers 625,500 prefilled syringes. Cartons labelled morphine sulfate 2 mg/mL hold a Dilaudid (hydromorphone) syringe of 0.5 mg/0.5 mL instead — the wrong opioid at the wrong dose.
The FDA classified the nationwide recall Class I, its most serious tier. About 31,935 multi-dose vials are affected, with particulate identified as nylon, glass and other materials, plus broken and leaking units.
Regulators say benzocaine and lidocaine gels, homeopathic tablets and amber necklaces carry real risks — a rare blood disorder, seizures, choking deaths — for little proven benefit in teething.
A multicentre reader study found AI raised early-career dentists' caries sensitivity from 67% to 82% without more false positives. Independent testing shows the same tools still miss early lesions.
A year of alerts at one hospital shows the safety pop-ups clinicians dismiss almost automatically — and why the field still cannot agree on how to measure the problem.
Most wellness apps make no disease claim and face no federal review. Into that gap, US states are writing their own AI-in-mental-health laws — four already diverge, leaving users unevenly protected.
In a UK trial of 1,956 critically ill adults, neither carbocisteine nor nebulised hypertonic saline shortened time on a ventilator, and each was tied to a specific harm.
Pooled across 48 trials, chatbots cut depression, anxiety and stress by small amounts. But a review of purpose-built mental health chatbots found crisis-referral protocols underdeveloped and missed suicidal ideation.
GE's Critical Care Suite gains an algorithm that flags misplaced enteric tubes on a chest X-ray — a complication that reviews of the practice have linked to respiratory harm and, in some cases, death.
A content analysis of every FDA cybersecurity safety communication from 2013 to 2025 finds a small corpus, rising over time, and 94% of the flagged vulnerabilities rated severe.
A 1,298-person randomized study found people using chatbots to work through medical scenarios did no better than people without them — even though the same chatbots, tested alone, got the right answer most of the time.
Researchers ran 960 responses through ChatGPT Health using clinician-written vignettes. Failures clustered at both extremes, and crisis safeguards activated unpredictably.
The landmark audit found the right diagnosis listed first in 34% of cases and correct triage in 57%. A newer heart-attack test exposes the dangerous edge: most atypical cases missed, and women.